These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17291441)

  • 1. An orthogonal dexamethasone-trimethoprim yeast three-hybrid system.
    Gallagher SS; Miller LW; Cornish VW
    Anal Biochem; 2007 Apr; 363(1):160-2. PubMed ID: 17291441
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrofolate reductase is not the target of trimethoprim in Saccharomyces cerevisiae.
    Barclay BJ; Nagel MG; Huang T
    Adv Exp Med Biol; 1993; 338():551-4. PubMed ID: 8304178
    [No Abstract]   [Full Text] [Related]  

  • 3. A three-hybrid system for detecting small ligand-protein receptor interactions.
    Licitra EJ; Liu JO
    Proc Natl Acad Sci U S A; 1996 Nov; 93(23):12817-21. PubMed ID: 8917502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An optimized dexamethasone-methotrexate yeast 3-hybrid system for high-throughput screening of small molecule-protein interactions.
    Baker K; Sengupta D; Salazar-Jimenez G; Cornish VW
    Anal Biochem; 2003 Apr; 315(1):134-7. PubMed ID: 12672422
    [No Abstract]   [Full Text] [Related]  

  • 5. Proceedings: Trimethoprim resistance in Escherichia coli.
    Breeze AS
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():98P. PubMed ID: 4156783
    [No Abstract]   [Full Text] [Related]  

  • 6. Ligand-dependent down-regulation of stably transfected human glucocorticoid receptors is associated with the loss of functional glucocorticoid responsiveness.
    Bellingham DL; Sar M; Cidlowski JA
    Mol Endocrinol; 1992 Dec; 6(12):2090-102. PubMed ID: 1491690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative topography of the catalytic sites of chromosomal dihydrofolate reductases and that of the enzyme encoded in R 67 plasmid from E. coli].
    Tu YX; Lebrun E; Bon F; Liu ZJ; Van Rapenbusch R
    C R Acad Sci III; 1988; 306(13):385-90. PubMed ID: 3136866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between ligand-receptor affinity and the transcription readout in a yeast three-hybrid system.
    de Felipe KS; Carter BT; Althoff EA; Cornish VW
    Biochemistry; 2004 Aug; 43(32):10353-63. PubMed ID: 15301533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directed evolution of trimethoprim resistance in Escherichia coli.
    Watson M; Liu JW; Ollis D
    FEBS J; 2007 May; 274(10):2661-71. PubMed ID: 17451440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interconvertible forms of Escherichia coli dihydrofolate reductase with different affinities for analogs of dihydrofolate.
    Pattishall KH; Burchall JJ; Harvey RJ
    J Biol Chem; 1976 Nov; 251(22):7011-20. PubMed ID: 791943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexamethasone negatively regulates the activity of a chimeric dihydrofolate reductase/glucocorticoid receptor protein.
    Israel DI; Kaufman RJ
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4290-4. PubMed ID: 8483945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a yeast assay for rapid screening of inhibitors of human-derived Pneumocystis carinii dihydrofolate reductase.
    Ma L; Jia Q; Kovacs JA
    Antimicrob Agents Chemother; 2002 Sep; 46(9):3101-3. PubMed ID: 12183283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydrofolate reductase from trimethoprim-resistant Escherichia coli MB 3746 and MB 3747. Purification, amino acid composition, and some kinetic properties.
    Poe M; Breeze AS; Wu JK; Short CR; Hoogsteen K
    J Biol Chem; 1979 Mar; 254(6):1799-805. PubMed ID: 33983
    [No Abstract]   [Full Text] [Related]  

  • 14. Development of a yeast protein fragment complementation assay (PCA) system using dihydrofolate reductase (DHFR) with specific additives.
    Shibasaki S; Sakata K; Ishii J; Kondo A; Ueda M
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):735-43. PubMed ID: 18670770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A GAL4-based yeast three-hybrid system for the identification of small molecule-target protein interactions.
    Henthorn DC; Jaxa-Chamiec AA; Meldrum E
    Biochem Pharmacol; 2002 May; 63(9):1619-28. PubMed ID: 12007565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and characterization of glucocorticoid receptor-binding sites in the human genome.
    Taniguchi-Yanai K; Koike Y; Hasegawa T; Furuta Y; Serizawa M; Ohshima N; Kato N; Yanai K
    J Recept Signal Transduct Res; 2010 Apr; 30(2):88-105. PubMed ID: 20163328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory mutants of dihydrofolate reductase in Escherichia coli K12.
    Sheldon R; Brenner S
    Mol Gen Genet; 1976 Aug; 147(1):91-7. PubMed ID: 785230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abrogation of glucocorticoid receptor dimerization correlates with dissociated glucocorticoid behavior of compound a.
    Robertson S; Allie-Reid F; Vanden Berghe W; Visser K; Binder A; Africander D; Vismer M; De Bosscher K; Hapgood J; Haegeman G; Louw A
    J Biol Chem; 2010 Mar; 285(11):8061-75. PubMed ID: 20037160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experiments to demonstrate a synergistic action between sulfonamides or trimethoprim and 5-fluro-2'-deoxyuridine against Escherichia coli.
    Then R
    Arzneimittelforschung; 1974 Dec; 24(12):1949-52. PubMed ID: 4281306
    [No Abstract]   [Full Text] [Related]  

  • 20. The purification and properties of the trimethoprim-resistant dihydrofolate reductase mediated by the R-factor, R388.
    Amyes SG; Smith JT
    Eur J Biochem; 1976 Jan; 61(2):597-603. PubMed ID: 2472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.